Found 8 matching trials
Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD PHASE3 The purpose of this study is to evaluate the efficacy and safety of Ilapraz...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3) PHASE3 Patients with endoscopically diagnosed active duodenal ulcer disease were e...
Show More Location
Peking University Third Hospital
Learn More & Join Trial
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer PHASE3 To demonstrate the non-inferiority of Ilaprazole 10 mg to the active contro...
Show More Location
Chung Ang University Hospital
Learn More & Join Trial
Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment PHASE3 The purpose of this study is to evaluate of efficacy and safety as H.pylori...
Show More Location
Soonchunhang University Hospital
Learn More & Join Trial
A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding PHASE3 The purpose of this study is to evaluate the efficacy of the study drug (Il...
Show More Location
Shanghai Jiaotong University Affiliate Ruijin Hospital
Learn More & Join Trial
Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese Patients PHASE2 This study is designed to evaluate the efficacy and tolerability of ilapraz...
Show More Location
Multiple Locations
Learn More & Join Trial
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients PHASE2 Patients with endoscopically diagnosed active duodenal ulcer disease were e...
Show More Location
Multiple Locations
Learn More & Join Trial
Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2) PHASE2 Patients with endoscopically diagnosed active duodenal ulcer disease were e...
Show More Location
Peking University Third Hospital
Learn More & Join Trial